Apricity has raised €6m in its Series A funding round from AXA’s Kamet Ventures.

The world’s first virtual fertility clinic’s total has now reached €8.8m.

Apricity combines medical excellence with human care and new technologies by applying AI to increase chances of conception.

Caroline Noublanche, CEO and Co-Founder of Apricity, said: “We are thrilled that for such a new company, we have seen such amazing support from AXA and Kamet Ventures.

“The fundraising will allow us to accelerate our go-to-market plans, especially with AXA, to better support and empower women and couples everywhere.

“The acquisition of Altrui is especially exciting for us. It gives us a great opportunity to realise our vision of becoming the number one route for accessing and using fertility services.”

This comes as the brand recently acquired Altrui, the UK leader in egg donation services.

Femtech ventures received more than $1bn in funding from 2015-2018, and the trend is increasing both in the UK and worldwide, with an expected value of $50bn by 2025.

Stéphane Guinet, CEO of Kamet Ventures, added: “Kamet’s investments in ‘femtech’ recognise that this is a critical area of healthcare, with huge scope for innovation.

“Our work with Apricity is an important step in AXA’s broader strategy of making a positive difference to the lives of as many people as possible, all over the world.”